AzTrials
AzTrials

Completely Edentulous PatientsBLXNCT06334770

Influence of Roxolid Implant Material on the Implant Stability Implant Stability

A study testing Roxolid implants and Titanium implants in people with Completely Edentulous Patients, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Fourteen completely edentulous patients were selected to participate in this study. From the outpatient clinic of Prosthodontic Department, Faculty of Dentistry, Ain Shams University. Read more about this study

Who is it for?
Ages 45 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Completely Edentulous Patients
What is being tested?
Roxolid implants and Titanium implants
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteEgypt
Study dates
15 Jun 2021to 12 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Completely edentulous patients as the last extraction should be at least six months before implant placement.
  • Patients with good oral hygiene.
  • Sufficient inter arch space (11 mm) which were diagnosed by mounted diagnostic casts.
  • Firm and healthy mucosa covering the residual alveolar ridge.

Who cannot join

  • - Heavy smokers.
  • Patients with para functional habits.
  • Patients had TMJ disorders.
  • Patients had systemic disease that could interfere with implant placement or affect bone healing such as; thyroid and uncontrolled diabetes.
  • Patients undergoing chemo and radiotherapy.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry of Dentistry Ainshams Univeristy

    Cairo

Other trials in Egypt

About this study

Official title: Influence of Roxolid Implant Material on the Implant Stability of Maxillary Implant Retained Overdenture

Fourteen completely edentulous patients were selected to participate in this study. From the outpatient clinic of Prosthodontic Department, Faculty of Dentistry, Ain Shams University.

After fabrication of complete denture for all patients, patients were randomly divided to:

Read more

Group A: Seven patients were rehabilitated with implant retained maxillary overdenture where four Straumann BLX® implant were inserted opposed by mandibular complete denture.

Group B: Seven patients were rehabilitated with implant retained maxillary overdenture where four conventional acid etched implants were inserted opposed by mandibular complete denture.

After implant placement using surgical guide, smart peg and ostell device were used to measure the primary stability of the implant then cover screw was placed and after six weeks, secondary stability was measured for both groups.

After four months, the second stage started in which exposure of the implant fixtures took place and pick up was carried out.

Patients were recalled frequently for post-insertion inspection and adjustment.

Read the detailed description

Background: long term success of implant restoration depends on many factors one of them is the sufficient implant stability which is lowered in compromised bone density sites such as the maxilla which is categorized as type III \& IV bone, so searching for new innovation and updates in implant material and features is very mandatory. So, the aim of this study was asses and compare between two implant materials roxolid versus traditional titanium on the primary and secondary stability.

Methods: eighteen completely edentulous patients were selected they all received maxillary implant retained overdentures and lower complete dentures, they were divided equally in to two groups according to the type of the material of the implants. Group A received a total number of 36 (Roxolid) Implants were made of roxolid material and Group B received a total number 36 (Titanium) implants were made of traditional titanium alloys. Implant stability was assed using ostell device, the primary implant stability was measured at the day of implant installation however, secondary implant stability was measured after six weeks of implant placement. Paired t-test was used to compare between primary and secondary stability in the same group and independent t-test was used to compare between the two groups with a significant level < 0.05.

Being tested
Roxolid implants, Titanium implants

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Roxolid implantsDevice

    Also called Straumann BLX® SLA implants

    four Straumann BLX® roxolid implant 15% zirconium and 85% titanium), 3.7 mm in diameter, and 10 mm in length.implants were selected with the following criteria: tapered, self-tapping, aggressively threaded,were inserted with novalock attachments.

  • Titanium implantsDevice

    Also called JD EVOLUTION PLUS implants

    four conventional acid etched pure implants tapered, self-tapping, threaded, two-piece, with the 10 mm length and 3.7 mm diameter were inserted with Sphero flex attachments.

Study groups in NCT06334770
Study groupRoleWhat they receive
Group( A) ROXOLID IMPLANTExperimentalNINE patients were rehabilitated with implant retained maxillary overdenture where four Straumann BLX® ROXOLID implant were inserted opposed by mandibular complete denture.
Receives: Device: Roxolid implants
Group (B) CONVENTIONAL TITANIUM IMPLANTActive comparatorNINE patients were rehabilitated with implant retained maxillary overdenture where four conventional titanium implants were inserted opposed by mandibular complete denture.
Receives: Device: Titanium implants

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. measuring primary at time of surgery

    using an Ostell device with a smart peg to measure primary stability at the time of implant placement and measuring secondary stability after six weeks of implant placement.

    Measured: same day of implant placement

Secondary outcomes (1)
  1. secondary implant stability after 6 weeks

    measuring secondary stability using ostell device and smart peg

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2024
  2. Study start15 Jun 2021
  3. Primary completion22 Jan 2022
  4. Study completion12 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06334770
Sponsor's protocol ID
FDASuRecD032136
Acronym
BLX
Status last verified
Mar 2024
First submitted
20 Mar 2024
Last updated
28 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: THE PROTOCOL OF OUR STUDY THAT WILL BE SHARED

Publications

  • Pandey C, Rokaya D, Bhattarai BP. Contemporary Concepts in Osseointegration of Dental Implants: A Review. Biomed Res Int. 2022 Jun 14;2022:6170452. doi: 10.1155/2022/6170452. eCollection 2022.

    PubMed 35747499
  • Thanasrisuebwong P, Pimkhaokham A, Jirajariyavej B, Bencharit S. Influence of the Residual Ridge Widths and Implant Thread Designs on Implant Positioning Using Static Implant Guided Surgery. J Prosthodont. 2023 Apr;32(4):340-346. doi: 10.1111/jopr.13557. Epub 2022 Jun 22.

    PubMed 35686699
  • El-Hady AIA, Eid HI, Mohamed SL, Fadl SM. Influence of titanium and titanium-zirconium alloy as implant materials on implant stability of maxillary implant retained overdenture: a randomized clinical trial. BMC Oral Health. 2024 Aug 6;24(1):902. doi: 10.1186/s12903-024-04692-x.

    PubMed 39107737

Questions about this trial

What is this clinical trial studying?

A study testing Roxolid implants and Titanium implants in people with Completely Edentulous Patients, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

measuring primary at time of surgery (time frame: same day of implant placement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06334770, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in